KN-62 2 mg | 98.77%
TargetMol
KN-62 is a potent and specific Ca2+/calmodulin-dependent protein kinase II (CaMKII) inhibitor with Ki of 0.9 μM.
More Information Supplier PageKN-62
Search Results
Oritavancin diphosphate 25 mg | 100.00%
TargetMol
Oritavancin diphosphate is a novel semisynthetic glycopeptide antibiotic which is being developed for the treatment of serious Gram-positive bacterial infections.
More Information Supplier PageOritavancin diphosphate
Timapiprant 100 mg | 99.89%
TargetMol
OC000459 is a potent and selective D prostanoid receptor 2 (DP2) antagonist (IC50: 13 nM).
More Information Supplier PageTimapiprant
LY2874455 2 mg | Purity Not Available
TargetMol
LY2874455 has been used in trials studying the treatment of Advanced Cancer.
More Information Supplier PageLY2874455
PTC-209 100 mg | 99.52%
TargetMol
PTC-209
AC1NS4RE 100 mg | 99.53%
TargetMol
AC1NS4RE
Indacaterol 25 mg | 100.00%
TargetMol
Indacaterol (Onbrez; Arcapta) is a β2-Adrenergic Agonist. The mechanism of action of indacaterol is as an Adrenergic beta2-Agonist.
More Information Supplier PageIndacaterol
Brexpiprazole 25 mg | 99.69%
TargetMol
Brexpiprazole is a partial agonist of human 5-hydroxytryptamine (5-HT) 5-HT1A and dopamine D2 receptors.
More Information Supplier PageBrexpiprazole
SP2509 25 mg | 99.49%
TargetMol
SP2509 is a specific histone demethylase LSD1 inhibitor(IC50 =13 nM).
More Information Supplier PageSP2509
BMS-833923 200 mg | 99.61%
TargetMol
BMS-833923, an orally bioavailable Smoothened antagonist, inhibits BODIPY cyclopamine binding to SMO in a dose-dependent manner (IC50: 21 nM).
More Information Supplier PageBMS-833923
